Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 6 days agoIf you’re in what’s considered an incredibly high-risk group, you may want to talk to your doctor...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoPeople 65 and older should get an additional dose 4 months after the previous one, according to the...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 7 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Disclosure of Antibody’s Equivalents Not Necessary to Satisfy Written Description and Indefiniteness...
JD Supra· 3 days agoThe United States Patent and Trademark Office’s (“USPTO”) Appeals Review Panel (“the Panel”) recently clarified that means-plus-function claims do not require that the specification disclose ...
Cessation to launch Phase IIa monoclonal antibody trial in opioid abuse
Clinical Trials Arena via Yahoo Finance· 4 days agoCessation Therapeutics will be advancing its investigational monoclonal antibody to a Phase IIa...
Pushing Medical Boundaries in Fight Against COVID-19
New Jersey Business Magazine· 5 hours agoThe state’s ongoing efforts to advance medical technology and healthcare delivery hold new relevance in the treatment of diseases such as COVID-19....
Beyond the lung: treating the GI symptoms of Covid-19
Pharmaceutical Technology via Yahoo Finance· 6 days agoCovid-19 is more than a respiratory disease, the presence of gastrointestinal (GI) symptoms are an...
AbTherx Opens Antibody Discovery Technologies Research Center
Digital Journal· 6 days agoPRESS RELEASE Published June 18, 2024 ACCESSWIRE New research center's world-class antibody discovery capabilities support a growing portfolio of Atlas™ Mice transgenic technologies ...
Extracellular targeted protein degrader removes antibodies in first test in humans
Nature· 6 days agoBiohaven’s BHV-1300 lowered levels of immunoglobulin G in the blood of healthy volunteers — a first...